News Roundup- Pitney Bowes (NYSE:PBI), CEL-SCI (NYSEMKT:CVM), Generex Biotechnology (OTCMKTS:GNBT), Lockheed Martin (NYSE:LMT) – The Cinema Post
Tuesday , April 25 2017
Home / Business News / News Roundup- Pitney Bowes (NYSE:PBI), CEL-SCI (NYSEMKT:CVM), Generex Biotechnology (OTCMKTS:GNBT), Lockheed Martin (NYSE:LMT)

News Roundup- Pitney Bowes (NYSE:PBI), CEL-SCI (NYSEMKT:CVM), Generex Biotechnology (OTCMKTS:GNBT), Lockheed Martin (NYSE:LMT)

Pitney Bowes Inc. (NYSE:PBI) (Full FREE Analysis of PBI And Be Sure To Notice The Intermediate Period) reported that several recent actions in Europe have advanced its long-term strategy to grow client and shareholder value. The firm exited a non-core product line in Norway, transitioned to a dealer sales network for its mailing businesses in six European markets where it had a smaller presence, and continued to shift additional client accounts to inside sales channels in major European markets. Whereas, shares of Pitney Bowes Inc. (NYSE:PBI) traded up of 1.82% to finished at USD24.57 with market capitalization of 4.89 billion. Separately, a research note to investors, 2 analysts rates its stocks at “Hold,” and 2 analysts rate it at “strong buy.”

CEL-SCI Corporation (NYSEMKT:CVM) (Read Latest Free Analytic Facts on CVM and Be Updated) reported that it has decided to sell common stock and warrants in a registered direct offering to European investors at a combined price of $0.76 for aggregate gross proceeds of a little over $1M. Share price of CEL-SCI Corporation (NYSEMKT:CVM) fell -19.05% to closed at $0.688 with the traded volume of 3.40 million shares as compared to the average volume of 288,120.00 in last session. The 1 analysts rate its stocks at ” “Buy,” according to a recent a pool of analysts rating.

Generex Biotechnology Corporation (OTCMKTS:GNBT) (Read Experts View Here on GNBT Upcoming Performance) released that its wholly owned subsidiary, Antigen Express has released a white paper outlining the advantages of its Ii-Key technology in the development of an effective Ebola vaccine. As, Generex Biotechnology Corporation (OTCMKTS:GNBT) has 1.22 beta factor with last traded share price of $0.0232 with positive change of 16.58%.

Lockheed Martin Corporation (NYSE:LMT) (What Market Forces Produce Volatility in LMT Share? Find Free Report Here) declared that it guided for low single digit sales drop in FY15 as compared to -1% consensus; LMT has released YoY sales drop nine quarters in a row. Lockheed Martin Corporation (NYSE:LMT) (What Market Forces Produce Volatility in LMT Share? Find Free Report Here) stock fell of -1.66% to closed at $172.615 with the total traded volume of 4.11 million shares. The consensus average revenue estimates are $11.28B for latest quarter, at the same time as 18 experts predict $11.63B revenues for the next three months of 2014.

For latest Market Updates Subscribes Here